Notice2024-19611

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 3, 2024

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 170 (Tuesday, September 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 170 (Tuesday, September 3, 2024)]
[Notices]
[Pages 71275-71276]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-19611]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-23IE]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Social and Economic Barriers to Receiving 
Optimal Services Along the Cancer Care Continuum'' to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on September 26, 2023 to obtain comments from 
the public and affected agencies. CDC did not receive comments related 
to the previous notice. This notice serves to allow an additional 30 
days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Social and Economic Barriers to Receiving Optimal Services Along 
the Cancer Care Continuum--New--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The purpose of this project is to: (1) examine and better 
understand social and economic barriers faced by colorectal, breast, 
and cervical cancer survivors and their caregivers at each stage of the 
Cancer Care Continuum (CCC); and (2) quantify the impact of

[[Page 71276]]

individual and compounded barriers on health outcomes along the CCC for 
survivors. CDC will use a mixed methods data collection and analysis 
approach. First, CDC will pull our sample from cancer registry data in 
California, North Carolina, and Texas based on inclusion criteria 
(received first cancer diagnosis of either breast, cervical or 
colorectal cancer in 2021; 21-75 years of age at time of diagnosis; are 
non-Hispanic Black/African American, non-Hispanic White, or Hispanic; 
alive at the time of data extraction/sample selection). Then, CDC will 
administer a Wave 1 (baseline) and Wave 2 (one-year follow-up) survey 
to cancer survivors, as well as a survey to their caregivers. 
Additionally, CDC will conduct interviews with selected survivors and 
caregivers as well as focus groups with representatives from patient/
survivor advocacy organizations.
    CDC will incorporate cancer registry data into the quantitative 
data analysis, and triangulate findings from the quantitative and 
qualitative data collection efforts. Results will be used to inform 
efforts aimed at increasing access to cancer care services, reducing 
the burden of cancers and closing the disparities gap. CDC requests OMB 
approval for an estimated 1,681 annual burden hours. There are no costs 
to respondents other than their time to participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Wave 1 Survivor Survey Respondents....  W1 Survey Instrument....           3,000               1           20/60
Wave 2 Survivor Survey Respondents....  W2 Survey Instrument....           1,200               1           20/60
Survivor Interviewees.................  Survivor Interview Guide              20               1               1
Caregiver Survey Respondents..........  Caregiver Survey                     900               1           15/60
                                         Instrument.
Caregiver Interviewees................  Caregiver Interview                   20               1               1
                                         Guide.
Patient Advocacy Group--Focus Group     Advocacy Representatives              16               1               1
 Participants.                           Focus Group Guide.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-19611 Filed 8-30-24; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on September 3, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.